Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Lancet Haematol. 2017 Mar 11;4(4):e165–e175. doi: 10.1016/S2352-3026(17)30030-3

Table 4.

Summary of long-term safety

Long-term safety 3th year 4th year 5th year >6th year
New AE with RX> 24 mos Total No of pts on RX 60 53 50 41
All grades Patients, n (%) 10 (17) 6 (11) 5 (10) 10 (24)
Events, n 13 14 10 18
Grade 1 – 2 Patients, n (%) 6 (60) 2 (33) 4 (80) 9 (90)
Events, n (%) 9 (69) 10 (71) 9 (90) 17 (94)
Grade 3 Patients, n (%) 4 (40) 4 (67) 1 (20) 1 (10)
Events, n (%) 4 (31) 4 (29) 1 (10) 1 (6)
Grade 4 Patients, n (%) 1 (17) 2 (40) 1 (10)
Events, n (%) 1 (7) 2 (20) 1 (6)
Deaths on Study Patients, n (%) 1 (6)
*

Grade 4 toxicities occurred only in patients with ET.